The Taxoids

@article{Eisenhauer2012TheT,
  title={The Taxoids},
  author={Elizabeth A. Eisenhauer and Jan Baptist Vermorken},
  journal={Drugs},
  year={2012},
  volume={55},
  pages={5-30}
}
SummaryPaclitaxel and docetaxel are 2 compounds from the new taxoid class of anti-cancer agents. Both drugs are very similar in preclinical activity, mechanism of action and spectrum of clinical activity. Some subtle differences in the intracellular retention of docetaxel may account for its lack of schedule-related myelosuppression and greater potency, and may be relevant to the skin toxicity and oedema which it produces. Early data suggest that there may be differing behaviour of… 

Figures and Tables from this paper

Evolving role of chemotherapy in castration-resistant prostate cancer
TLDR
It is found that the novel taxane cabazitaxel (plus prednisone) was found to prolong overall survival in metastatic castration-resistant patients who had progressed during or after docetaxel therapy.
Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment
TLDR
The role of microtubule-interfering chemotherapeutic agents in treatment of newly diagnosed and recurrent ovarian cancer, as well as common mechanisms of chemoresistance, are discussed.
Pre-application of arsenic trioxide may potentiate cytotoxic effects of vinorelbine/docetaxel on neuroblastoma SK-N-SH cells.
  • K. Qi, Yang Li, W. Weng
  • Medicine
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  • 2019
A Case of Docetaxel-Induced Rhabdomyolysis
TLDR
A 48-year-old female with breast cancer who developed bilateral proximal leg pain and inability to walk two weeks after the third cycle of docetaxel and cyclophosphamide is presented, one of the few reports of docETaxel-induced rhabdomyolysis.
Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status
TLDR
It is demonstrated that p53-dependent NAG-1 induction is linked to cell death and that NAG -1 induction without accompanying alteration of antiapoptosis protein Bcl-2 family members may not lead to cancer cell death.
Pharmacognostic studies on Taxus baccata L.: A brilliant source of Anti-cancer agents.
TLDR
The present investigation was undertaken to establish standardization profile of Taxus baccata L.baccata with the help of pharmacognostic parameters, which is not done before, to authenticate and avoid adulteration in the raw material.
Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel
TLDR
Treating MCF7 breast cells with proteasome inhibitor sensitizes cells to Docetaxel-induced apoptosis and possibly overcomes chemoresistance.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 192 REFERENCES
Docetaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of metastatic breast cancer.
TLDR
Docetaxel monotherapy has shown impressive activity as second-line therapy in patients with metastatic breast cancer who had relapsed while receiving adjuvant therapy or who had progressive disease following previous treatment, with overall response rates of 53 and 58% reported in 2 studies.
Preclinical evaluation of docetaxel (Taxotere).
TLDR
Docetaxel has significant in vivo antitumor activity in the different models generally used for the preclinical evaluation of drugs and is cytotoxic at clinically relevant concentrations against fresh human tumor biopsy specimens in a soft agar cloning system.
Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancer.
TLDR
Docetaxel appears to be effective in the treatment of platinum-refractory ovarian cancer patients and its toxic effects are considered to be of greatest concern.
Phase I trial of taxol in patients with advanced cancer.
TLDR
The frequent occurrence early in the study of acute cardiovascular and pulmonary toxicity suggestive of hypersensitivity reactions was decreased in frequency and severity by prolonging the infusions and premedication with corticosteroids and antihistamines.
A phase II trial of taxol in metastatic melanoma
TLDR
The data confirm that Taxol has definite although limited activity against metastatic melanoma and no patient experienced acute allergic reactions.
Activity of Docetaxel (Taxotere) in Small Cell Lung Cancer
Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.
TLDR
It is concluded that taxol is an active agent in the treatment of metastatic breast cancer and that it warrants continued study, and is conducting a phase I trial of taxol plus doxorubicin.
Taxol: a review of its preclinical in vivo antitumor activity.
  • W. Rose
  • Biology
    Anti-cancer drugs
  • 1992
TLDR
In the manner evaluated, taxol plus either adriamycin, cisplatin, cyclophosphamide or etoposide (VP-16) were not meaningfully more efficacious than the more effective drug in each of those combination settings.
Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results.
TLDR
Taxol is an active agent for the treatment of metastatic non-small-cell lung cancer and should be combined with other agents, and granulocyte colony-stimulating factor should be used to ameliorate myelosuppression.
Paclitaxel plus carboplatin in the treatment of ovarian cancer.
TLDR
A dose-finding study of the combination of paclitaxel and carboplatin in combination with cisplatin against ovarian cancer finds this treatment is well tolerated and yields satisfactory antitumor results.
...
1
2
3
4
5
...